Standout Papers

Clinical Significance of Programmed Death-1 Ligand-1 and Programmed Death-1 Ligand-2 Expression... 2005 2026 2012 2019 647
  1. Clinical Significance of Programmed Death-1 Ligand-1 and Programmed Death-1 Ligand-2 Expression in Human Esophageal Cancer (2005)
    Yuichiro Ohigashi, Masayuki Sho et al. Clinical Cancer Research

Immediate Impact

65 by Nobel laureates 20 from Science/Nature 233 standout
Sub-graph 1 of 18

Citing Papers

A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis
2021 StandoutScienceNobel
Treg-expressed CTLA-4 depletes CD80/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells
2021 StandoutNobel
2 intermediate papers

Works of Noriko Otsuki being referenced

Preferential contribution of B7‐H1 to programmed death‐1‐mediated regulation of hapten‐specific allergic inflammatory responses
2003
Differential binding properties of B7-H1 and B7-DC to programmed death-1
2003

Author Peers

Author Last Decade Papers Cites
Noriko Otsuki 768 142 51 894 200 18 1.5k
Raghvendra M. Srivastava 774 283 26 862 87 20 1.4k
Guozhong Qin 602 373 15 481 77 24 1.4k
Rupal Ramakrishnan 939 357 24 798 54 21 1.6k
Teruaki Sekine 605 436 29 558 142 44 1.5k
Yi Yang 524 564 54 565 136 36 1.8k
Charlotte Read 1001 234 21 168 87 20 1.5k
Mayumi Kawada 456 635 22 649 255 20 1.5k
Kazunori Hata 482 235 45 308 362 41 1.3k
P.R. Bock 258 286 9 181 737 28 1.4k
Seema Dubey 407 511 114 406 149 15 1.3k

All Works

Loading papers...

Rankless by CCL
2026